DEA to Again Revise Telemedicine Prescribing Guidelines

A statement issued May 3 by DEA Administrator Anne Milgram says the DEA, coordinating with the Health and Human Services Department, is submitting a draft temporary rule to the Office of Management and Budget for the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Substances.”

Read More »

Overcoming Social Determinants of Health to Improve Medication Adherence

The healthcare industry still has a medication adherence problem. It’s come up time and time again in recent years, but progress is slow, particularly among patients living in pharmacy deserts or facing other geographic or socioeconomic challenges. Meanwhile, avoidable medical costs due to nonadherence make up 20% of healthcare spending in the U.S. How can technology address these gaps?

Read More »

Bringing Prescribing and Fulfillment of Specialty Medications Into the 21st Century

Often, to prescribe the specialty drug, the physician must write a letter requesting the health plan to cover it and provide lab and/or test results to verify medical necessity. Meanwhile, the patient, who typically has a complex, difficult-to-manage health condition, waits needlessly for a drug that they hope will improve their health and quality of life.

Read More »